|Bid||0.00 x 1200|
|Ask||0.00 x 3000|
|Day's range||12.62 - 13.06|
|52-week range||7.67 - 17.29|
|PE ratio (TTM)||N/A|
|Earnings date||30 Jul 2018 - 3 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||23.00|
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of human diseases. Lexicon Pharmaceuticals’s insiders have invested 295.42k shares in theRead More...
Label expansion of a few prominent drugs along with pipeline updates were the key areas of focus for investors in the biotech space.
The The Woodlands, Texas-based company said it had a loss of 27 cents per share. Losses, adjusted for pretax gains, came to 31 cents per share. The results exceeded Wall Street expectations. The average ...
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 29 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...